News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn’s Faculty innovators are celebrated
On December 6th, the Penn Center for Innovation held its 7th annual Celebration of Innovation at the Singh Center of Nanotechnology.
Penn Spinout Verismo Therapeutics Creates New R&D Facility in CIC on Market St
Verismo plans to use this space for its in-house translational research.
Penn Spinout Avisi Technologies Raises $4.06 Million in Seed Round To Be Used to Develop Glaucoma Treatment Device
Avisi was founded in 2017 by Penn students Rui Jing J., the company's CEO, and Brandon Kao and Adarsh Battu, who were studying business and engineering.
Vetigenics Founder Nicola Mason Featured on CBS 60 Minutes for Canine Cancer Research
Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.
Avisi Technologies Closes $4 Million Seed Round to Further Develop Glaucoma Treatment Device
Penn spinout Avisi Technologies raised $4.06 million in a seed round led by Accanto Partners.
Penn Today Interviews John Swartley About PCI’s Impact
In the article, Swartley discusses some key highlights from FY22, including the major impact Penn technologies have made on patients.
Pennovation Works Welcomes New Director Denita Henderson
Henderson, Penn alumna and Philly native, will spearhead the implementation of Pennovation’s long-range strategic plan, including development of the site, marketing, communications and leasing.
Penn Dental Medicine Study Finds That Cavity-causing Microbes Have the Ability to Form Superorgranisms that Can Crawl on Teeth
A Penn Dental Medicine study found that cavity-causing microbes have the ability to form superorgranisms that can sprout “limbs” that propel them to“leap” to quickly spread on the tooth surfaces.
Neuralert Technologies included in TIME’s List of the Best Inventions
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS
CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.